The Brain Tumor Segmentation (BraTS) Challenge: Local Synthesis of Healthy Brain Tissue via Inpainting
Authors:
Florian Kofler,
Felix Meissen,
Felix Steinbauer,
Robert Graf,
Stefan K Ehrlich,
Annika Reinke,
Eva Oswald,
Diana Waldmannstetter,
Florian Hoelzl,
Izabela Horvath,
Oezguen Turgut,
Suprosanna Shit,
Christina Bukas,
Kaiyuan Yang,
Johannes C. Paetzold,
Ezequiel de da Rosa,
Isra Mekki,
Shankeeth Vinayahalingam,
Hasan Kassem,
Juexin Zhang,
Ke Chen,
Ying Weng,
Alicia Durrer,
Philippe C. Cattin,
Julia Wolleb
, et al. (81 additional authors not shown)
Abstract:
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition time series typically starts with an already pathological scan. This poses problems, as many algorithms are designed to analyze healthy brains and provide no guarantee for images featuring lesions. Examples include, but ar…
▽ More
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition time series typically starts with an already pathological scan. This poses problems, as many algorithms are designed to analyze healthy brains and provide no guarantee for images featuring lesions. Examples include, but are not limited to, algorithms for brain anatomy parcellation, tissue segmentation, and brain extraction. To solve this dilemma, we introduce the BraTS inpainting challenge. Here, the participants explore inpainting techniques to synthesize healthy brain scans from lesioned ones. The following manuscript contains the task formulation, dataset, and submission procedure. Later, it will be updated to summarize the findings of the challenge. The challenge is organized as part of the ASNR-BraTS MICCAI challenge.
△ Less
Submitted 22 September, 2024; v1 submitted 15 May, 2023;
originally announced May 2023.
Learn-Morph-Infer: a new way of solving the inverse problem for brain tumor modeling
Authors:
Ivan Ezhov,
Kevin Scibilia,
Katharina Franitza,
Felix Steinbauer,
Suprosanna Shit,
Lucas Zimmer,
Jana Lipkova,
Florian Kofler,
Johannes Paetzold,
Luca Canalini,
Diana Waldmannstetter,
Martin Menten,
Marie Metz,
Benedikt Wiestler,
Bjoern Menze
Abstract:
Current treatment planning of patients diagnosed with a brain tumor, such as glioma, could significantly benefit by accessing the spatial distribution of tumor cell concentration. Existing diagnostic modalities, e.g. magnetic resonance imaging (MRI), contrast sufficiently well areas of high cell density. In gliomas, however, they do not portray areas of low cell concentration, which can often serv…
▽ More
Current treatment planning of patients diagnosed with a brain tumor, such as glioma, could significantly benefit by accessing the spatial distribution of tumor cell concentration. Existing diagnostic modalities, e.g. magnetic resonance imaging (MRI), contrast sufficiently well areas of high cell density. In gliomas, however, they do not portray areas of low cell concentration, which can often serve as a source for the secondary appearance of the tumor after treatment. To estimate tumor cell densities beyond the visible boundaries of the lesion, numerical simulations of tumor growth could complement imaging information by providing estimates of full spatial distributions of tumor cells. Over recent years a corpus of literature on medical image-based tumor modeling was published. It includes different mathematical formalisms describing the forward tumor growth model. Alongside, various parametric inference schemes were developed to perform an efficient tumor model personalization, i.e. solving the inverse problem. However, the unifying drawback of all existing approaches is the time complexity of the model personalization which prohibits a potential integration of the modeling into clinical settings. In this work, we introduce a deep learning based methodology for inferring the patient-specific spatial distribution of brain tumors from T1Gd and FLAIR MRI medical scans. Coined as Learn-Morph-Infer the method achieves real-time performance in the order of minutes on widely available hardware and the compute time is stable across tumor models of different complexity, such as reaction-diffusion and reaction-advection-diffusion models. We believe the proposed inverse solution approach not only bridges the way for clinical translation of brain tumor personalization but can also be adopted to other scientific and engineering domains.
△ Less
Submitted 25 October, 2022; v1 submitted 7 November, 2021;
originally announced November 2021.
